Previous studies have also demonstrated that FCGR2A is the susceptibility gene for Kawasaki disease (KD), while levels in methylation of its CpG site promoter could act as a crucial biomarker for optimizing intravenous immunoglobulin (IVIG) therapy (Kuo et al., 2015). Here, FCGR2A is linked to Kawasaki disease.